We recently published a list of 11 Best 3D Printing and Additive Manufacturing Stocks to Buy. In this article, we are going ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics ...

First, sepiapterin is a precursor compound that is rapidly absorbed and ... 58,000 people with phenylketonuria globally. About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company ...

PTC Therapeutics Inc (NASDAQ:PTCT) reported strong financial performance in 2024, with fourth quarter revenue of $213 million and full year revenue of $807 million, exceeding guidance. The company ...